Intensity of warfarin coagulation in the antiphospholipid syndrome

Current Rheumatology Reports

Volumn 12, Issue 1, 2010, Pages 64-69

  Crowther, Mark A ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Anticoagulation; Antiphospholipid syndrome; Lupus anticoagulant; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTIBODY TITER; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BLEEDING; BLOOD CLOTTING TIME; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; OSTEOPOROSIS; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; REVIEW; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; STROKE; THROMBOEMBOLISM; THROMBOSIS; TREATMENT DURATION; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 77249148762     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0070-9     Document Type: Review

References (27)

1. MH Rosove PM Brewer 1992 Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients Ann Intern Med 117 303 308 1:STN:280:DyaK38zksVWmtQ%3D%3D 1637025
2. S Miyakis MD Lockshin T Atsumi, et al. 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295 306 10.1111/j.1538-7836. 2006.01753.x 1:CAS:528:DC%2BD28XisVSjuro%3D 16420554
3. CL Conley RC Hartmann 1952 A haemorrhage disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus J Lab Clin Invest 31 621 622
4. B Giannakopoulos F Passam S Rahgozar SA Krilis 2007 Current concepts on the pathogenesis of the antiphospholipid syndrome Blood 109 422 430 10.1182/blood-2006-04-001206 1:CAS:528:DC%2BD2sXivVykur4%3D 16985176 (Pubitemid 46105935)
5. W Shi SA Krilis BH Chong, et al. 1990 Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population Aust NZ J Med 20 231 236 1:STN:280:DyaK3czitFWrug%3D%3D
6. P Vila MC Hernandez MF Lopez-Fernandez J Batlle 1994 Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects Thromb Haemost 72 209 213 1:CAS:528:DyaK2MXis1Chur8%3D 7831653
7. M Galli D Luciani G Bertolini T Barbui 2003 Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood 101 1827 1832 10.1182/blood-2002-02-0441 1:CAS:528:DC%2BD3sXhslCrtrk%3D 12393574 (Pubitemid 36237580)
8. V Janardhan PA Wolf CS Kase, et al. 2004 Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study Stroke 35 736 741 10.1161/01.STR.0000117575.48205.2D 14764933 (Pubitemid 38280851)
9. D Erkan MJ Harrison R Levy, et al. 2007 Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals Arthritis Rheum 56 2382 2391 10.1002/art.22663 1:CAS:528: DC%2BD2sXovFSgurs%3D 17599766 (Pubitemid 47173586)
10. A Ruffatti T Del Ross M Ciprian, et al. 2009 Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a multicentre, retrospective follow-up study Ann Rheum Dis 68 397 399 10.1136/ard.2008.096669 1:STN:280:DC%2BD1M7jslWmsA%3D%3D 18812393
11. T Hereng M Lambert E Hachulla, et al. 2008 Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients Lupus 17 11 15 10.1177/0961203307084724 1:STN:280:DC%2BD2sjlt1Wksw%3D%3D 18089677
12. D Erkan JT Merrill Y Yazici, et al. 2001 High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin Arthritis Rheum 44 1466 1467 10.1002/1529-0131(200106)44:6<1466::AID-ART242>3.0. CO;2-C 1:STN:280:DC%2BD3MzksVOmtA%3D%3D 11407709 (Pubitemid 32537548)
13. CA Clark KA Spitzer MA Crowther, et al. 2007 Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss J Rheumatol 34 992 996 1:CAS:528:DC%2BD2sXmtV2rtL0%3D 17407219
14. W Lim MA Crowther JW Eikelboom 2006 Management of antiphospholipid antibody syndrome: a systematic review JAMA 295 1050 1057 10.1001/jama.295.9. 1050 1:CAS:528:DC%2BD28XhvFymsrk%3D 16507806 (Pubitemid 43313721)
15. S Schulman E Svenungsson S Granqvist 1998 Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group Am J Med 104 332 338 10.1016/S0002-9343(98)00060-6 1:STN:280:DyaK1c3jsF2guw%3D%3D 9576405 (Pubitemid 28211022)
16. C Kearon SR Kahn G Agnelli, et al. 2008 Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 454S 545S 10.1378/chest.08-0658 1:CAS:528:DC%2BD1cXptVKhsrY%3D 18574272 Published erratum appears in Chest 2008, 134:892. This paper provides an up-to-date evidence guideline covering most aspects of the management of thromboembolism (Pubitemid 351892971)
17. C Kearon JS Ginsberg DR Anderson, et al. 2004 Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor J Thromb Haemost 2 743 749 10.1046/j.1538-7836.2004.00698.x 1:STN:280:DC%2BD2c3gt1Omtg%3D%3D 15099280 (Pubitemid 40192487)
18. SR Levine RL Brey BC Tilley, et al. 2004 Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke JAMA 291 576 584 10.1001/jama.291.22.2702 1:CAS:528:DC%2BD2cXhtVylurc%3D 14762036
19. MA Khamashta MJ Cuadrado F Mujic, et al. 1995 The management of thrombosis in the antiphospholipid-antibody syndrome N Engl J Med 332 993 997 10.1056/NEJM199504133321504 1:STN:280:DyaK2M7ptFKgtg%3D%3D 7885428
20. R Kunz AD Oxman 1998 The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials BMJ 317 1185 1190 1:STN:280:DyaK1M%2FhtlOruw%3D%3D 9794851
21. MA Crowther JS Ginsberg J Julian, et al. 2003 A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome N Engl J Med 349 1133 1138 10.1056/NEJMoa035241 1:CAS:528:DC%2BD3sXnsV2jtb4%3D 13679527 Published erratum appears in N Engl J Med 2003, 349:2577; N Engl J Med 2004, 351:200 (Pubitemid 37122325)
22. G Finazzi R Marchioli V Brancaccio, et al. 2005 A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS) J Thromb Haemost 3 848 853 10.1111/j.1538-7836.2005.01340.x 1:CAS:528:DC%2BD2MXltlOitL4%3D 15869575 (Pubitemid 41632808)
23. A Oden M Fahlen 2002 Oral anticoagulation and risk of death: a medical record linkage study BMJ 325 1073 1075 10.1136/bmj.325.7372.1073 12424167
24. TP Baglin DM Keeling HG Watson 2006 British Committee for Standards in Haemotology: Guidelines on oral anticoagulation (warfarin): third edition-2005 update Br J Haematol 132 277 285 10.1111/j.1365-2141.2005.05856.x 1:STN:280:DC%2BD28%2Fit1eqtg%3D%3D 16409292 (Pubitemid 43381534)
25. AYY Lee MN Levine RI Baker, et al. 2003 Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 146 153 10.1056/NEJMoa025313 1:CAS:528:DC%2BD3sXltlOqsrg%3D 12853587 (Pubitemid 36818784)
26. IA Greer C Nelson-Piercy 2005 Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy Blood 106 401 407 10.1182/blood-2005- 02-0626 1:CAS:528:DC%2BD2MXmtleqs7c%3D 15811953 (Pubitemid 40981229)
27. F Dentali E Manfredi M Crowther W Ageno 2005 Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy J Thromb Haemost 3 21 23 10.1111/j.1538-7836. 2005.01516.x (Pubitemid 43086081)